BlackRock increased its holdings of Sino Biopharmaceutical Limited (01801.HK) by about 369,500 shares, with each share priced at approximately HK$82.07.

According to the latest information obtained by China Fortune Financial APP, the Hong Kong Stock Exchange disclosed that on May 21, BlackRock increased its holdings of Sino Biopharmaceutical Limited (01801.HK) by 369,453 shares at a price of 82.0651 Hong Kong dollars per share, with a total amount of approximately 30.3192 million Hong Kong dollars. After the increase, the latest number of shares held is approximately 87.2809 million shares, and the latest shareholding ratio is 5.02%.